0000000000089267
AUTHOR
M. Beer
Energy-energy correlations in hadronic final states from Z0 decays
We have studied the energy-energy angular correlations in hadronic final states from Z0 decay using the DELPHI detector at LEP. From a comparison with Monte Carlo calculations based on the exact second order QCD matrix element and string fragmentation we find that Λ(5)/MS = 104-20 +25 (stat.)-20 +25(syst.)-00 +30(theor.) MeV, which corresponds to αs(91 GeV) = 0.106± 0.003 (stat.)±0.003(syst.)-0.000 +0.003(theor.). The theoretical error stems from different choices for the renormalization scale of αs. In the Monte Carlo simulation the scale of αs as well as the fragmentation parameters have been optimized to described reasonably well all aspects of multihadron production.
Production of strange particles in the hadronic decays of the Z0
Abstract An analysis of the production of strange particles from the decays of the Z 0 boson into multihadronic final states is presented. The analysis is based on about 90 000 selected hadronic Z 0 decays collected by the DELPHI detector at LEP in 1990. K s 0 , K ∗± , Λ( Λ ) and Ξ − ( Ξ + ) have been identified by their characteristic decays. The measured production cross sections are compared with predictions of the Lund Monte Carlo tuned to data at PEP/PETRA energies.
The Electrostatic Expansion of Linear Polyelectrolytes: Effects of Gegenions, Co-ions, and Hydrophobicity
The molar mass and ionic strength dependence of the dimensions of hydrophobically modified poly(vinylpyridinium) cations are demonstrated to be almost perfectly described by a theoretical expression derived on the basis of only excluded volume considerations. Generally, the effective charge density of the polyions decreases significantly with increasing hydrophobicity and with increasing polarizability of the gegenions. Unexpectedly, the intrinsic excluded volume effect which becomes dominating at high ionic strength not only depends on the hydrophobicity of the polyion but also significantly increases with decreasing polarizability of the gegenions (i.e., if the iodide gegenions are replac…
Measurement of the Z$^0$ branching fraction to b quark pairs using the boosted sphericity product
Abstract From a sample of about 120 000 hadronic Z 0 decays, using a technique based on a separation of the different event categories in the boosted sphericity product, the fraction of b b decays has been measured to be 0.219 ± 0.014 (stat)± 0.019 (syst). Using the DELPHI determination of the hadronic Z 0 width, this corresponds to a partial width τ b b = 378 ± 42 MeV (in good agreement with the standard model prediction of ∼-380 MeV). Combining this measurement with the determinations based on events with high p t leptons gives an estimate for the branching ratio of b into leptons at LEP of (11.2 ± 1.2)%, consistent with previous determinations.
Probleme der Stadieneinteilung beim fortgeschrittenen Blasentumor
Eine bis zu 50% reichende Unterschatzung der Blasencarcinome in den Stadien pTa bis hin zum Stadium pT3a, eine uber 50% reichende Uberschatzung der Stadien pT3b und pT4 und eine richtige Aussage in nur 44% der Falle kennzeichnen die Problematik der exakten klinischen Stadienerfassung von Blasentumoren in der „Vor-CT-Aera“ [2].
Experimental study of the triple-gluon vertex
Abstract In four-jet events from e+e− →Z0 →multihadrons one can separate the three principal contributions from the triple-gluon vertex, double gluon-bremsstrahlung and the secondary quark-antiquark production, using the shape of the two-dimensional angular distributions in the generalized Nachtmann-Reiter angle θ NR ∗ and the opening angle of the secondary jets. Thus one can identify directly the contribution from the triple-gluon vertex without comparison with a specific non-QCD model. Applying this new method to events taken with the DELPHI-detector we get for the ratio of the colour factor Nc to the fermionic Casimir operator C F : N c C F = 2.55 ± 0.55 ( stat. ) ± 0.4 ( fragm. + models…
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure
Metagenomic high-throughput sequencing (mHTS) is a hypothesis-free, universal pathogen detection technique for determination of the DNA/RNA sequences in a variety of sample types and infectious syndromes. mHTS is still in its early stages of translating into clinical application. To support the development, implementation and standardization of mHTS procedures for virus diagnostics, the European Society for Clinical Virology (ESCV) Network on Next-Generation Sequencing (ENNGS) has been established. The aim of ENNGS is to bring together professionals involved in mHTS for viral diagnostics to share methodologies and experiences, and to develop application recommendations. This manuscript aims…